||Leszek Lisowski PhD, MBA, Group Leader, Translational Vectorology Group (TVG); Manager, Vector and Genome Engineering Facility (VGEF).
Leszek [pronounced: Leshek] is a world vectorology expert with over 15 years of experience in developing and manufacturing viral vectors for human gene therapy. He was born in a small town in Western Poland. After high school, he received a prestigious Academic Excellence and Leadership Scholarship and enrolled at the University of Bridgeport, Bridgeport, CT, USA where he earned his B.S. in Biology. He subsequently joined a doctorate program at Cornell University in New York. He earned his PhD in Molecular Biology and Genetics from the laboratory of Prof. Michel Sadelain, MD PhD at the Memorial Sloan Kettering Cancer Center (MSKCC), for his work on lentiviral vectors for the treatment of β-thalassemia and assessment of vector toxicity and the risk of insertional oncogenesis.
He then joined the laboratory of Prof. Mark A. Kay, MD PhD at the Stanford University School of Medicine, where Leszek performed his postdoctoral training, studying AAV vectors’ evolution via multispecies interbreeding and retargeting of rAAV. He was subsequently recruited by the Salk Institute for Biological Studies in La Jolla, CA where he ran the Gene Transfer, Targeting and Therapeutics Facility (GT3). While in La Jolla, he earned his MBA degree from UC San Diego Rady School of Management and co-founded LogicBio Therapeutics, a gene therapy company.
In October 2015, Leszek was recruited by CMRI to establish and run the Vector and Genome Engineering Facility (VGEF) and to establish his independent research program, the Translational Vectorology Group (TVG). In addition to being Group Leader at CMRI, Leszek is a conjoint Senior Lecturer at the University of Sydney and holds the title of Honorary Faculty at University College London (UCL), London, UK. In December 2016, Leszek was awarded the prestigious grant “Kosciuszko” from the Polish Department of Defence and was appointed the title of Visiting Group Leader at the Military Institute of Hygiene & Epidemiology (MIHE), Biological Threats Identification and Countermeasure Centre in Pulawy, Poland, where he established and heads the Department of Cell Transfection and Vectorology.
d: +61 2 8865 2818 | Skype: CMRI_VGEF
f: +61 2 8865 2801 | e: firstname.lastname@example.org